Financier Worldwide discusses M&A in the healthcare and life sciences sector with Frank Aquila at Sullivan & Cromwell, covering topics such as recent trends in deal volume and value, strategic priorities that are driving acquirers to pursue transactions, rising interest in M&A involving AI diagnostics, patient engagement platforms and technology-enabled healthcare services, the main obstacles dealmakers face in completing transactions, and the outlook for a strong M&A market in 2026.
Read the full article: Q&A: M&A in the Healthcare and Life Sciences Sector //
Source: https://www.financierworldwide.com/qa-ma-in-the-healthcare-and-life-sciences-sector